PL168968B1 - Method of manufacturing an antitussive drug - Google Patents

Method of manufacturing an antitussive drug

Info

Publication number
PL168968B1
PL168968B1 PL91298950A PL29895091A PL168968B1 PL 168968 B1 PL168968 B1 PL 168968B1 PL 91298950 A PL91298950 A PL 91298950A PL 29895091 A PL29895091 A PL 29895091A PL 168968 B1 PL168968 B1 PL 168968B1
Authority
PL
Poland
Prior art keywords
dextromethorphan
sodium
cough
liquid
antitussive
Prior art date
Application number
PL91298950A
Other languages
English (en)
Polish (pl)
Inventor
Ronald L Smith
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PL168968B1 publication Critical patent/PL168968B1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL91298950A 1990-10-31 1991-10-21 Method of manufacturing an antitussive drug PL168968B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60629490A 1990-10-31 1990-10-31
PCT/US1991/007773 WO1992007559A1 (en) 1990-10-31 1991-10-21 Dextromethorphan antitussive compositions

Publications (1)

Publication Number Publication Date
PL168968B1 true PL168968B1 (en) 1996-05-31

Family

ID=24427392

Family Applications (1)

Application Number Title Priority Date Filing Date
PL91298950A PL168968B1 (en) 1990-10-31 1991-10-21 Method of manufacturing an antitussive drug

Country Status (13)

Country Link
EP (1) EP0555411A1 (cs)
JP (1) JPH06502428A (cs)
AU (1) AU663857B2 (cs)
CA (1) CA2129676C (cs)
CZ (1) CZ79593A3 (cs)
FI (1) FI931934A7 (cs)
HU (1) HUT64216A (cs)
IE (1) IE913792A1 (cs)
MX (1) MX9101831A (cs)
PL (1) PL168968B1 (cs)
PT (1) PT99380B (cs)
SK (1) SK42593A3 (cs)
WO (1) WO1992007559A1 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274026B (it) * 1994-03-01 1997-07-14 Acraf Composizione antitosse
SE9601528D0 (sv) * 1996-04-23 1996-04-23 Pharmacia Ab Transdermally administered dextromethorphan as antitissue agent
ES2196574T3 (es) 1997-07-15 2003-12-16 Walter Burghart Procedimiento para la preparacion de soluciones estables de acido acetilsalicilico.
US6245785B1 (en) 1998-11-30 2001-06-12 Warner Lambert Company Dissolution of triprolidine hydrochloride
US6846495B2 (en) * 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
DE102007000521A1 (de) 2007-10-18 2009-04-23 Renate Conrad Hustenpräparat
US10888620B2 (en) 2016-11-28 2021-01-12 Johnson & Johnson Consumer Inc. Liquid compositions for treating cough or cold symptoms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294819A (en) * 1980-08-18 1981-10-13 Bristol-Myers Company Alkaline analgesic capsule
US4454140A (en) * 1982-09-07 1984-06-12 Hoffmann-La Roche Inc. Nasal administration of dextromethorphan
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
US4892877A (en) * 1987-10-27 1990-01-09 Richardson-Vicks Inc. Antitussive liquid compositions containing phenol

Also Published As

Publication number Publication date
IE913792A1 (en) 1992-05-22
CA2129676C (en) 1997-09-30
AU8915891A (en) 1992-05-26
CA2129676A1 (en) 1992-05-14
PT99380A (pt) 1992-09-30
HUT64216A (en) 1993-12-28
JPH06502428A (ja) 1994-03-17
SK42593A3 (en) 1993-09-08
MX9101831A (es) 1992-06-05
EP0555411A1 (en) 1993-08-18
HU9301254D0 (en) 1993-07-28
CZ79593A3 (en) 1994-01-19
FI931934A0 (fi) 1993-04-29
FI931934L (fi) 1993-05-31
PT99380B (pt) 1999-04-30
WO1992007559A1 (en) 1992-05-14
AU663857B2 (en) 1995-10-26
FI931934A7 (fi) 1993-05-31

Similar Documents

Publication Publication Date Title
US5196436A (en) Dextromethorphan antitussive compositions
AU681672B2 (en) Preparations containing silicon dioxide to improve the taste thereof
US9492541B2 (en) Phenylepherine containing dosage form
US20050232987A1 (en) Dosage form containing a morphine derivative and another drug
US5055461A (en) Anesthetic oral compositions and methods of use
JPH09502201A (ja) プロピオン酸非ステロイド系抗炎症剤のアミノ酸塩とうっ血除去剤、去痰剤、抗ヒスタミン剤及び鎮咳剤のうち少くとも1種を含有した組成物
US5730997A (en) Tastemasked liquid pharmaceutical delivery system
US5037823A (en) Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process
US5100898A (en) Antitussive liquid compositions containing dyclonine
US4892877A (en) Antitussive liquid compositions containing phenol
PL168968B1 (en) Method of manufacturing an antitussive drug
JPH0141608B2 (cs)
JPH08506808A (ja) 呼吸障害治療用組成物の製造における鎮痛剤s(+)対掌体の利用
JPH09504293A (ja) マグネシウムアルミニウムシリケート及び複数の活性成分を含有した速溶解性剤形
US5155105A (en) Pharmaceutical methods for relief of dysmenorrhea and/or premenstrual syndrome and process
CA2010022C (en) Anesthetic oral compositions
AU672279B2 (en) Compositions containing caffeine and S(+)-ibuprofen or S(+)-flurbiprofen or S(+)-ketoprofen
EP0529898A1 (en) Potentiation of the antitussive effect of dextromethorphan with acetaminophen (paracetamol)
JP2000095707A (ja) 苦味を有する薬物を含有する口中溶解型又は咀嚼型固形内服医薬組成物
JP3150642B2 (ja) 新規な抗痙攣性及び抗炎症性組成物並びにそれらの製造方法
JP2002528483A (ja) 顆粒状で自由流動性の薬剤組成物、およびその経口投与のためのストロー状の投与形態
JPH0262823A (ja) 鎮咳経口組成物
NZ243613A (en) Tablet comprising praziquantel, pyrantel pamoate and oxantel pamoate in synergistic proportions for treatment of nematode infestations